Ploutarchos Tzoulis
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Dynamic OGTT-Derived Indices Outperform Fasting HOMA-2 for Detecting Dysglycemia in Transfusion-Dependent β-Thalassemia.
Journal: Mediterranean journal of hematology and infectious diseases
Published: May 01, 2026
Six-Month Real-World Effectiveness, Persistence and Safety of Low-to-Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study.
Journal: Diabetes, obesity & metabolism
Published: February 01, 2026
A Descriptive Preanalytical Survey of Procedures Followed for the Screening of Glucose Dysregulation in Thalassemia Centers: Implications for Clinical Practice and Call for Harmonization.
Journal: Mediterranean journal of hematology and infectious diseases
Published: January 26, 2026
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with New Diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM): Implications for Clinical Practice.
Journal: Mediterranean journal of hematology and infectious diseases
Published: November 07, 2025
A real-world study of tirzepatide for weight loss in adults without diabetes mellitus.
Journal: International journal of obesity (2005)
Published: August 31, 2025
Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.
Journal: Journal of diabetes and its complications
Published: August 07, 2025
Fasting Plasma Glucose Levels within the High Normal Range are Associated with a Significantly Increased Risk of Future Dysglycemia in Transfusion-Dependent β Thalassemia: A Decade-Long Multicenter Retrospective Analysis.
Journal: Mediterranean journal of hematology and infectious diseases
Published: July 26, 2025
Post-Load Plasma Glucose Increase (PG-gap) as a Risk Factor for Developing Dysglycemia in Patients with Transfusion-Dependent β-Thalassemia (β-TDT): Retrospective Analysis over 8 Years.
Journal: Mediterranean journal of hematology and infectious diseases
Published: June 12, 2025
Could Plasma Glucose (PG) Increment (PG%) Expand the Clinical Weight of OGTT? Preliminary Findings in 19 TDT Patients (β-TDT) with Normal Glucose Tolerance.
Journal: Mediterranean journal of hematology and infectious diseases
Published: March 09, 2025
A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization.
Journal: Mediterranean journal of hematology and infectious diseases
Published: November 28, 2024
Empagliflozin: a wonder drug for the treatment of SIAD?
Journal: Frontiers in endocrinology
Published: June 22, 2024
Last Updated: 09/26/2026